more expansive exports sector. Meanwhile, government investment still played a key role in propelling the economy, although it slowed down somewhat, accelerating in the previous quarter. The company
been mainly driven by improvements in tourism and industries related to the export sector. In contrast, provinces that rely on agriculture have not yet seen a clear pick-up, despite higher agricultural
Untitled 1 กองทุนนีล้งทุนกระจุกตัวในหมวดอุตสาหกรรม Health Care จึงมีความเส่ียงท่ีผู้ลงทุน อาจสูญเสียเงินลงทุนจ านวนมาก กองทุนเปิดไทยพาณิชย์ Genomic Revolution SCB Genomic Revolution (SCBGENOME) (ชนิด
-634-0225 Fax 02-634-0135 www.interpharma.co.th Type of Revenue 1st Quarter 2020 1st Quarter 2019 Change MB % MB % MB % 1. Wellness & Anti-Aging 47.77 49.18 31.87 37.52 15.90 49.90% 2. Aesthetic
-1- AIT (VP-SEC) 025E/2023 August 10, 2023 Subject: Management's Discussion and Analysis of Operating Results for Q2-2023 To: The President of the Stock Exchange of Thailand Summary of Operations Q2
-1- AIT (VP-SEC) 014E/2024 May 9, 2024 Subject: Management's Discussion and Analysis of Operating Results for Q1-2024 To: The President of the Stock Exchange of Thailand Summary of Operations Q1-2024
20230807-ADVANC-MDA-2Q23-EN Classification: Internal 2Q23 MD&A Advanced Info Service Plc. 1 Executive Summary Core businesses growth from profitability focus amid economic uncertainties In 2Q23 Thai
Microsoft Word - ACE MDA Q2 23 - EN 1 No. ACE-ACC-3/2023 11 August 2023 Subject Management Discussion and Analysis for the period ended 30 June 2023 To President The Stock Exchange of Thailand
MDA_EN_1Q20 Management Discussion and Analysis For the 1 st Quarter 2020 ended May 31, 2020 AEON Thana Sinsap (Thailand) Public Company Limited (“the Company”) has already submitted the consolidated
MDA_EN_1Q20 Management Discussion and Analysis For the 1 st Quarter 2020 ended May 31, 2020 AEON Thana Sinsap (Thailand) Public Company Limited (“the Company”) has already submitted the consolidated